Skip to main content
. 2021 Jun 4;11:689587. doi: 10.3389/fonc.2021.689587

Figure 1.

Figure 1

Study profile. DCIS, ductal carcinoma in situ; EBC, early-stage breast cancer; HER2, human epidermal growth factor receptor 2; MBC, metastatic breast cancer; RTZ, reference trastuzumab; TCHP, docetaxel–carboplatin–RTZ or CT-P6–pertuzumab.